HRT Financial’s Albemarle ALB Stock Holding History

HRT Financial’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.5M	Buy	153,100 +135,300	+760%	+$23.1M	0.07%	251
2025 Q4	$2.52M	Buy	+17,800	New	+$2.02M	0.01%	1157
2023 Q3	–	Sell	-1,600	Closed	-$356K	–	2338
2023 Q2	$356K	Buy	+1,600	New	+$327K	﹤0.01%	1530

Other funds holding ALB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's ALB Position: Q1 2026 in Review

HRT Financial sold out of Albemarle (ALB) in Q1 2026, closing a stake of 87,513 shares — an estimated $14.9M sold.

HRT Financial first reported a position in ALB in Q4 2019 and held it in 13 quarters. The position peaked at $12.4M in Q4 2025. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

HRT Financial reported no remaining Albemarle position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 87,513 Albemarle shares in Q1 2026, an estimated $14.9M.
HRT Financial first reported a position in Albemarle in Q4 2019 and held it in 13 quarters.
HRT Financial's Albemarle position peaked at $12.4M in Q4 2025.
982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.